secwatch / observer
8-K filed May 7, 2026, 7:59 PM ET ticker CLRCF CIK 0001903392
other material confidence high sentiment neutral materiality 0.60

ClimateRock shareholders approve extension to November 2, 2026 and redeem 4,543 shares for ~$59.9 million

ClimateRock

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001213900-26-053305
form_type
8-K
ticker
CLRCF
cik
0001903392
company_name
ClimateRock
filed_at
2026-05-07T23:59:59+00:00
discovered_at
2026-05-14T18:02:33.264492+00:00
generated_at
2026-05-14T22:04:09.314198+00:00
sec_items
["5.03", "5.07", "9.01"]
event_type
other_material
sentiment
neutral
materiality_score
0.6
calibrated_materiality_score
0.6
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001213900-26-053305
json_url
https://secwatch.observer/filing/0001213900-26-053305.json
markdown_url
https://secwatch.observer/filing/0001213900-26-053305.md
text_url
https://secwatch.observer/filing/0001213900-26-053305.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/1903392/000121390026053305/0001213900-26-053305-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/1903392/000121390026053305/ea0289583-8k_climate.htm
generated_by_model
deepseek-v4-flash:cloud
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null

Source-grounded claims

27cf7903424a5560a89b8705cc3999e4aa4fcd50

ClimateRock reported a fiscal year change.

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. The disclosure contained in

SEC 8-K Item 5.03/5.05/5.06 confidence 0.4 SEC evidence

Comparable filings

AEIS

AEIS stockholders approve doubling of authorized shares to 140M and expansion of equity plan to 4.9M shares

ADVANCED ENERGY INDUSTRIES INC May 8, 2026, 7:59 PM ET other_material Items 5.02, 5.07, 5.03, 9.01

same fact type: governance_change same SEC item: 5.03, 5.07, 9.01 same event type: other_material similar materiality

This filing

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. The disclosure contained in

Comparable filing

the amendment increases the number of authorized shares of common stock from 70,000,000 shares to 140,000,000 shares. The amendment became effective upon the filing of a Certificate of Amendment to the Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of the State of Delaware on May 7, 2026.

Filing page SEC filing

FBIN

Fortune Brands shareholders approve removal of supermajority voting, board declassification

Fortune Brands Innovations, Inc. May 7, 2026, 7:59 PM ET other_material Items 5.03, 5.07, 9.01

same fact type: governance_change same SEC item: 5.03, 5.07, 9.01 same event type: other_material similar materiality

This filing

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. The disclosure contained in

Comparable filing

On May 6, 2026, the Company filed with the Secretary of State of the State of Delaware an Amended and Restated Certificate of Incorporation, the form of which was included as Appendix B to the Company's definitive Proxy Statement.

Filing page SEC filing

RYZ

Ryerson stockholders approve 1.5M share increase in 2014 incentive plan; director Calhoun departs

Ryerson Holding Corp May 6, 2026, 7:59 PM ET other_material Items 5.02, 5.03, 5.07, 9.01

same fact type: governance_change same SEC item: 5.03, 5.07, 9.01 same event type: other_material similar materiality

This filing

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. The disclosure contained in

Comparable filing

On April 30, 2026, at the Annual Meeting, upon the recommendation of the Board, the stockholders of the Company approved a proposal to amend and restate the Company’s Amended and Restated Certificate of Incorporation (the “Amended and Restated Charter”) to provide for the exculpation of certain of the Company’s officers in specific circumstances, as permitted by Delaware law.

Filing page SEC filing

CVNA

Carvana stockholders approve 5-for-1 stock split, adopt new 2026 incentive plan

CARVANA CO. May 6, 2026, 7:59 PM ET other_material Items 5.02, 5.03, 5.07, 9.01

same fact type: governance_change same SEC item: 5.03, 5.07, 9.01 same event type: other_material similar materiality

This filing

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. The disclosure contained in

Comparable filing

At the Annual Meeting, the Company's stockholders approved an amendment (the "Amendment") to the Company's Amended and Restated Certificate of Incorporation to effect a five-for-one forward stock split of the Company's Class A common stock and Class B common stock (the "Stock Split") and to proportionately increase the number of authorized shares of Class A common stock and Class B common stock (the "Authorized Share Increase").

Filing page SEC filing

LEGT

Legato Merger Corp. III shareholders approve extension to August 8, 2026 for Einride business combination

Legato Merger Corp. III May 6, 2026, 7:59 PM ET other_material Items 2.03, 5.07, 5.03, 9.01

same fact type: governance_change same SEC item: 5.03, 5.07, 9.01 same event type: other_material similar materiality

This filing

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. The disclosure contained in

Comparable filing

As previously disclosed, on November 12, 2025, Legato Merger Corp. III, a Cayman Islands exempted company (the “Company”), Einride AB, a limited liability company formed under the laws of Sweden (“Einride”), and Einride Cayman Sub Limited, a Cayman Islands exempted company and a direct, wholly-owned subsidiary of Einride (“Merger Sub”), entered into a Business Combination Agreement (“BCA”). Pursuant to the BCA, the Company will merge with and into Merger Sub, with Merger Sub surviving the merger (“Merger”). As a result of the Merger, Merger Sub will continue as a direct, wholly-owned subsidiary of Einride, with the shareholders of the Company becoming shareholders of Einride. On May 5, 2026, the Company held an extraordinary general meeting (the “Meeting”) to approve the following resolutions: ● to resolve as a special resolution, that the Company’s amended and restated memorandum and articles of association as adopted by special resolution dated February 5, 2024 with effect from Febru

Filing page SEC filing

BSX

Boston Scientific stockholders approve charter amendments and ESPP share increase at 2026 annual meeting

BOSTON SCIENTIFIC CORP May 5, 2026, 7:59 PM ET other_material Items 5.03, 5.07, 9.01

same fact type: governance_change same SEC item: 5.03, 5.07, 9.01 same event type: other_material similar materiality

This filing

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. The disclosure contained in

Comparable filing

approved amendments (the “Charter Amendments”) to the Company’s Third Restated Certificate of Incorporation, as described in the Company’s definitive proxy statement for the Annual Meeting filed on March 18, 2026 (the “Proxy Statement”) to (a) eliminate supermajority voting provisions contained therein, as well as to eliminate certain inoperative provisions and implement other clarifying and correcting changes, and (b) provide for exculpation of certain of our officers in certain circumstances as permitted by Delaware law. The Charter Amendments became effective upon the filing of the Company’s Fourth Restated Certificate of Incorporation with the Secretary of State of the State of Delaware on May 5, 2026.

Filing page SEC filing

SLXN

Silexion shareholders approve 50M share increase, expanded equity plan, and 1-for-10 reverse split

Silexion Therapeutics Corp May 5, 2026, 7:59 PM ET other_material Items 5.03, 5.07, 9.01

same fact type: governance_change same SEC item: 5.03, 5.07, 9.01 same event type: other_material similar materiality

This filing

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. The disclosure contained in

Comparable filing

At the extraordinary general meeting of Silexion Therapeutics Corp (the “ Company ”) originally held on April 28, 2026 and reconvened on May 5, 2026 (the “ Meeting ”), the shareholders of the Company duly approved a resolution serving as an effective amendment to paragraph 5 of the Company’s amended and restated memorandum of association (the “ Memorandum Amendment”) , which increased the Company’s authorized share capital, as described in Item 5.07 below.

Filing page SEC filing

INSP

Inspire Medical shareholders approve declassification, 2.6M-share increase to equity plan

Inspire Medical Systems, Inc. May 5, 2026, 7:59 PM ET other_material Items 5.02, 5.07, 5.03, 9.01

same fact type: governance_change same SEC item: 5.03, 5.07, 9.01 same event type: other_material similar materiality

This filing

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. The disclosure contained in

Comparable filing

On May 1, 2026, the Company filed a Certificate of Amendment to the Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of the State of Delaware, which became effective upon filing.

Filing page SEC filing

Source: SEC EDGAR
accession 0001213900-26-053305

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.